Literature DB >> 32623067

Does abnormal ductus venosus pulsatility index at the first-trimester effect on adverse pregnancy outcomes?

Şafak Yılmaz Baran1, Hakan Kalaycı2, Gülşen Doğan Durdağ2, Selçuk Yetkinel2, Alev Arslan3, Esra Bulgan Kılıçdağ2.   

Abstract

AIM: The ductus venosus pulsatility index for veins (DV PIV) has become a popular marker of the first-trimester scan. The aim of this study is to search for any difference between groups with normal and abnormal DV PIV values in terms of adverse pregnancy outcomes.
METHODS: We retrospectively evaluated 556 women whose first-trimester scan was performed. The ductus venosus pulsatility indices were examined at singleton pregnancies between 11 and 14 weeks of gestation. Patients were categorized as Group-I with normal DV PIV (DV PIV ≥ 0.73, ≤1.22) and as Group-II with abnormal DV PIV. Group-II was subgrouped as Group-IIA which composed of patients with DV PIV < 0.73 and as Group-IIB with DV PIV > 1.22.
RESULTS: There were 451 subjects in Group-I and 105 subjects in Group-II (Group-IIA = 32 and Group-IIB = 73). The comparisons between major groups revealed a statistically significant increase about miscarriage (p = 0.002), stillbirth (p < 0.001), small for gestational age (p = 0.033), low birth weight (p < 0.001), fetal growth restriction (p = 0.048), and major congenital heart defect (p=<0.001) in Group-II. This difference is mainly due to Group-IIB. There is no difference in preterm delivery, preeclampsia and gestational diabetes between Group I and II.
CONCLUSION: Routinely monitoring DIV PIV as a first-trimester screening should provide valuable information regarding adverse pregnancy outcomes such as miscarriage, stillbirth, small for gestational age, low birth weight, fetal growth restriction and major congenital heart defect.
Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  1st trimester ultrasound screening for aneuploidy and anomalies; Diagnostic ultrasound and prenatal diagnosis; Doppler-diagnostic

Year:  2020        PMID: 32623067     DOI: 10.1016/j.jogoh.2020.101851

Source DB:  PubMed          Journal:  J Gynecol Obstet Hum Reprod        ISSN: 2468-7847


  2 in total

1.  First-Trimester Fetal Hepatic Artery Examination for Adverse Outcome Prediction.

Authors:  Bartosz Czuba; Piotr Tousty; Wojciech Cnota; Dariusz Borowski; Agnieszka Jagielska; Mariusz Dubiel; Anna Fuchs; Magda Fraszczyk-Tousty; Sylwia Dzidek; Anna Kajdy; Grzegorz Świercz; Sebastian Kwiatkowski
Journal:  J Clin Med       Date:  2022-04-08       Impact factor: 4.964

2.  Risk Assessment of the Increased Occurrence of Congenital Cardiac and Non-Cardiac Defects in Fetuses with a Normal Karyotype after Assisted Fertilization in Comparison to Natural Fertilization Based on Ultrasound Diagnostics.

Authors:  Dawid Serafin; Beniamin Oskar Grabarek; Dariusz Boroń; Andrzej Madej; Bartosz Czuba
Journal:  J Clin Med       Date:  2021-11-29       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.